3rd EURORDIS Multi-Stakeholder Symposium on Improving Patients’ Access to Rare Disease Therapies
An exceptional two-day event not to be missed!
Attend to take part in discussions with patient advocates, policy makers, payers, HTA bodies, clinicians, healthcare industry executives and investors on how to improve patients’ access to rare disease medicines. Learn more about actions planned ahead of the European elections in May 2019.
Views expressed by participants will go towards producing a roadmap document, which will offer practical and implementable solutions and set out the commitment of all players, working towards the goal of accelerating the development of, and guaranteeing timely and universal access to, rare disease therapies.
This roadmap will be broadly disseminated to European and national institutions ahead of the May 2019 European parliamentary elections.
This event is recommended for:
- Patient advocates
- Payers, health technology assessment (HTA) bodies, and national Competent Authorities
- Policy makers and regulators
- Clinicians and academics
- Pharmaceutical and biotech industry leaders
- Consultants and Investors